SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001382963-15-000129
Filing Date
2015-10-30
Accepted
2015-10-30 18:41:13
Documents
2
Period of Report
2015-07-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1572
2 POA poamerrifield.htm EX-24 3038
  Complete submission text file 0001382963-15-000129.txt   5956
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 617-639-1500
JUNIPER PHARMACEUTICALS INC (Issuer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MERRIFIELD C ANN (Reporting) CIK: 0001247224 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-10352 | Film No.: 151188851